2nd Circ. Refuses To Revive Complaints In Eliquis MDL
The Second Circuit on Tuesday upheld the dismissal of more than a dozen claims in multidistrict litigation alleging that Pfizer Inc. and Bristol-Myers Squibb Co. didn't warn consumers of the risks...To view the full article, register now.
Already a subscriber? Click here to view full article